top of page
Search

Thyroid Cancer Types for MRCP Part 1

TL;DR

Endo: Thyroid Cancer Types (Papillary to Anaplastic) is a core MRCP Part 1 topic centred on recognising tumour origin, spread patterns, and key markers. Papillary and follicular cancers are differentiated with favourable prognosis, while medullary and anaplastic cancers are clinically distinct and higher risk. Most exam questions rely on pattern recognition—histology, tumour markers, and metastatic routes. Focus on distinguishing features rather than memorising isolated facts.


Why this matters

Thyroid cancer is a consistently tested topic in MRCP Part 1, integrating endocrinology, oncology, pathology, and genetics. Questions are rarely obscure—they are designed to test whether you can:

  • Identify tumour type from a clinical vignette

  • Recognise spread patterns

  • Recall tumour markers

  • Apply management principles

A structured understanding allows rapid elimination of incorrect options in single-best-answer questions.

For a broader roadmap, see the MRCP Part 1 overview.


Core sections

1. Classification of Thyroid Cancer

A simple exam framework divides thyroid cancers into:

  1. Differentiated thyroid cancers (DTC)

    • Papillary carcinoma

    • Follicular carcinoma

  2. Neuroendocrine tumour

    • Medullary carcinoma

  3. Undifferentiated tumour

    • Anaplastic carcinoma

2. High-yield comparison table

Feature

Papillary

Follicular

Medullary

Anaplastic

Origin

Follicular cells

Follicular cells

C cells

Undifferentiated

Frequency

~80% (most common)

10–15%

~5%

Rare

Spread

Lymphatic

Haematogenous

Mixed

Local invasion

Marker

Thyroglobulin

Thyroglobulin

Calcitonin

None

Histology

Orphan Annie nuclei, psammoma bodies

Capsular invasion

Amyloid

Pleomorphic cells

Prognosis

Excellent

Good

Intermediate

Very poor

3. The 5 most tested subtopics

(1) Papillary thyroid carcinoma

  • Most common thyroid malignancy

  • Associated with radiation exposure (especially childhood)

  • Spreads via lymphatics

  • Classic histology:

    • Orphan Annie nuclei

    • Psammoma bodies

Exam insight: Cervical lymph node involvement does not significantly worsen prognosis.

(2) Follicular thyroid carcinoma

  • Associated with iodine deficiency

  • Spreads via bloodstream

  • Common metastases:

    • Bone

    • Lung

Key point: Diagnosis requires capsular or vascular invasion → cannot be confirmed on FNAC.

(3) Medullary thyroid carcinoma

  • Originates from parafollicular C cells

  • Produces:

    • Calcitonin

    • Carcinoembryonic antigen (CEA)

  • Associated with MEN2 syndrome

Clinical relevance: Always exclude phaeochromocytoma before thyroid surgery.

(4) Anaplastic thyroid carcinoma

  • Highly aggressive and rapidly progressive

  • Typically affects elderly patients

  • Presents with:

    • Rapidly enlarging neck mass

    • Dysphagia, hoarseness

Exam clue: “Rapid onset, fatal course, undifferentiated tumour.”

(5) Tumour markers and follow-up

  • Thyroglobulin → used in differentiated cancers

  • Calcitonin → specific for medullary carcinoma

Exam tip: Rising marker levels indicate recurrence.

4. 10 high-yield points (rapid revision)

  1. Papillary carcinoma is the most common thyroid cancer

  2. Radiation exposure increases papillary cancer risk

  3. Papillary spreads via lymphatics

  4. Follicular spreads via blood

  5. Bone metastasis suggests follicular carcinoma

  6. Medullary carcinoma produces calcitonin

  7. MEN2 syndrome is linked to medullary cancer

  8. Amyloid deposition is seen in medullary carcinoma

  9. Anaplastic carcinoma has the worst prognosis

  10. FNAC cannot distinguish follicular adenoma from carcinoma


Practical examples / mini-cases

MCQ:

A 45-year-old woman presents with a solitary thyroid nodule. FNAC suggests a follicular neoplasm. There is no lymphadenopathy. What is the next best step?

A. Measure calcitoninB. Total thyroidectomyC. Lobectomy for histological diagnosisD. Radioiodine therapy

Correct answer: C. Lobectomy for histological diagnosis

Explanation: Follicular carcinoma is diagnosed by identifying capsular or vascular invasion, which cannot be assessed on FNAC. Therefore, surgical excision is required for definitive diagnosis.

Practise similar questions in the Free MRCP MCQs.


Medical student studying thyroid cancer types for MRCP Part 1 using notes and textbooks

Common pitfalls (5 bullets)

  • Confusing lymphatic spread (papillary) with haematogenous spread (follicular)

  • Assuming FNAC can confirm follicular carcinoma

  • Forgetting calcitonin as a marker for medullary cancer

  • Missing MEN2 association in medullary carcinoma

  • Underestimating the aggressiveness of anaplastic carcinoma


FAQs

1. Which thyroid cancer is most common in MRCP Part 1?

Papillary thyroid carcinoma is the most common and most frequently tested. Questions often focus on histology and lymphatic spread.

2. How do you differentiate papillary from follicular carcinoma?

Papillary spreads via lymphatics and has characteristic nuclear features, while follicular spreads via blood and requires histological evidence of invasion.

3. What is the key marker for medullary thyroid cancer?

Calcitonin is the primary marker and is useful for diagnosis and monitoring recurrence.

4. Why can’t FNAC diagnose follicular carcinoma?

Because diagnosis depends on capsular or vascular invasion, which requires histological examination of tissue architecture.

5. Which thyroid cancer has the worst prognosis?

Anaplastic carcinoma, due to its rapid progression and resistance to treatment.


Ready to start?

To strengthen retention and exam performance:

Suggested related reading:

  • Thyroid Function Tests for MRCP Part 1

  • MEN Syndromes for MRCP Part 1


Sources

 
 
 

Comments

bottom of page